After completing Korean medical device registration, adverse events are reported to the Ministry of Food and Drug Safety (MFDS) through the Korea Institute of Drug Safety and Risk Management (KIDS). Manufacturers must submit detailed reports promptly, following specific guidelines, to ensure ongoing safety monitoring and compliance with regulatory requirements.